CYB561D2: A Protein Involved in Cellular Processes (G11068)

Target Name: CYB561D2

NCBI ID: G11068

CYB561D2

CYB561D2: A Protein Involved in Cellular Processes

CYB561D2 (101F6) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of cytoplasmic proteins, which are a type of protein that is found in the cytoplasm of cells. CYB561D2 is also known as 101F6, which is a gene that encodes it.

The protein encoded by the 101F6 gene is a 25 kDa protein that is composed of 196 amino acids. It has a molecular weight of 21.9 kDa and a calculated pI of 6.9. CYB561D2 is expressed in a variety of tissues and cells in the body, including the brain, heart, and kidneys. It is also expressed in the placenta, which is the tissue in which the developing fetus is nourished.

One of the functions of CYB561D2 is to play a role in the regulation of cellular processes that are important for the survival and proper functioning of cells. For example, CYB561D2 has been shown to be involved in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs.

CYB561D2 has also been shown to be involved in the regulation of the cytoskeleton, which is the structure that gives cells shape and helps them maintain their shape as they divide. The cytoskeleton is made up of a variety of proteins, including microtubules and actin filaments, and it plays a crucial role in the movement and division of cells.

In addition to its role in cell adhesion and cytoskeleton regulation, CYB561D2 has also been shown to be involved in the regulation of a variety of other cellular processes. For example, it has been shown to be involved in the regulation of cell growth, cell survival, and the response to stimuli.

Given its involvement in so many cellular processes, CYB561D2 is a potential drug target. Researchers are currently working to develop compounds that can inhibit the activity of CYB561D2 and use it as a therapy for a variety of diseases. For example, some researchers are studying the potential uses of CYB561D2 as a treatment for cancer, while others are investigating its potential as a treatment for other diseases, such as heart disease and neurological disorders.

In addition to its potential as a drug target, CYB561D2 is also a potential biomarker. Researchers are interested in using it as a diagnostic tool to study the effects of drugs on various tissues and cells. For example, they are studying the effects of drugs on the expression of CYB561D2 in different tissues, such as the brain and the heart, to see how these effects might be related to the treatment outcomes of these drugs.

Overall, CYB561D2 is a protein that is expressed in various tissues of the body that is involved in a variety of cellular processes. It is a potential drug target and biomarker, and researchers are currently working to investigate its role in the regulation of cellular processes and its potential as a therapeutic agent.

Protein Name: Cytochrome B561 Family Member D2

Functions: Transmembrane reductase that may use ascorbate as an electron donor in the cytoplasm and transfer electrons across endoplasmic reticulum membranes to reduce monodehydro-L-ascorbate radical and iron cations Fe(3+) in the lumen of that compartment

The "CYB561D2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CYB561D2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets